Development and characterization of bimodal chrono modulated drug delivery of methylphenidate hydrochloride

Development and characterization of bimodal chrono modulated drug delivery of methylphenidate hydrochloride

The study's goal was to develop chrono modulated pulsatile tablets of methylphenidate hydrochloride with an extended-release pattern in the morning and an immediate burst release in the afternoon for exaggerated symptoms of attention deficit hyperactivity disorder match the circadian rhythm of...

Full description

Bibliographic Details
Main Authors:	Rajasekhar Reddy Poonuru, Ashwini Penala
Format:	Article
Language:	English
Published:	Elsevier 2023-12-01
Series:	Food Hydrocolloids for Health
Subjects:	Methylphenidate hydrochloride Chrono modulated Attention deficit hyperactivity disorder Bimodal release
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667025923000122

Similar Items

Prevalence of methylphenidate use by university students in Campos dos Goytacazes, RJ
by: Fernanda Fraga Pessanha, et al.
Published: (2014-08-01)

Effectiveness of methylphenidate and PUFA for the treatment of patients with ADHD: A double-blinded randomized clinical trial
by: Mahbobeh Firouzkouhi Moghaddam, et al.
Published: (2017-05-01)

ADDH And Methylphenidate Response
by: J Gordon Millichap
Published: (1994-07-01)

The Effect of Methylphenidate on the Hearing of Children with Attention Deficit Hyperactivity Disorder
by: Onur İsmi, et al.
Published: (2018-07-01)

Is dopamine transporter gene effective on therapeutic response of methylphenidate in ADHD patients?
by: Fatemeh Moharrari, et al.
Published: (2015-04-01)

Is dopamine transporter gene effective on therapeutic response of methylphenidate in ADHD patients?
by: Fatemeh Moharrari, et al.
Published: (2015-01-01)

Attention Deficit Hyperactivity Disorder and Methylphenidate: When Society Misunderstands Medicine
by: David D. Kaminester
Published: (2020-12-01)

A convolution‐based in vitro‐in vivo correlation model for methylphenidate hydrochloride delayed‐release and extended‐release capsule
by: Pawan Kumar Gupta, et al.
Published: (2024-01-01)

Methylphenidate extended-release oral suspension for the treatment of attention-deficit/hyperactivity disorder: a practical guide for pharmacists
by: Caballero J, et al.
Published: (2017-10-01)

The Effects of Endurance Training Along with Methylphenidate Consumption on Balance in Male Rats with Attention Deficit Hyperactivity Disorder
by: حسن عبدی, et al.
Published: (2017-07-01)

Does Methylphenidate Affect Cystometric Parameters in Spontaneously Hypertensive Rats?
by: Khae Hawn Kim, et al.
Published: (2015-06-01)

The Efficacy of Magnesium Supplementation in Children With Attention Deficit Hyperactivity Disorder under Treatment With Methylphenidate: A Randomized Controlled Trial
by: Seyed Gholamreza Noorazar, et al.
Published: (2021-01-01)

Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011
by: Inmyung Song, et al.
Published: (2016-10-01)

Methylphenidate-induced Psychotic Symptoms in 65-Year-Old Female with ADHD
by: Elliyeh Ghadrdan, et al.
Published: (2018-08-01)

Comparison of duloxetine and methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder
by: Nasrin Dodangi, et al.
Published: (2016-06-01)

Comparative Efficacy of Iranian and Foreign Methylphenidate in Children with Attention Deficit Hyperactive Disorder
by: M Karahmadi, et al.
Published: (2008-04-01)

The effect of adding ferrous sulfate to methylphenidate on attention-deficit/hyperactivity disorder in children
by: Gholamreza Panahandeh, et al.
Published: (2017-01-01)

Ginkgo biloba as an adjunct to methylphenidate in the treatment of attention deficit hyperactivity disorder in children: review of articles
by: Paria Hebrani, et al.
Published: (2015-04-01)

Effectiveness and safety of methylphenidate for ADHD in population between 6 and 19 years: a systematic review
by: José Calleja, et al.
Published: (2012-09-01)

Ginkgo biloba as an adjunct to methylphenidate in the treatment of attention deficit hyperactivity disorder in children: review of articles
by: Paria Hebrani, et al.
Published: (2015-01-01)

Does methylphenidate treatment affect functional and structural ocular parameters in patients with attention deficit hyperactivity disorder? - A prospective, one year follow-up study
by: Pınar Bingöl-Kızıltunç, et al.
Published: (2022-01-01)

The Effects of Endurance Training along with Methylphenidate Consumption on Behavioral Symptoms in Male Rats with Attention Deficit Hyperactivity Disorder
by: Hassan Abdi, et al.
Published: (2018-05-01)

Brief psychosis induced by methylphenidate in a child with attention deficit disorder: a case report and literature review
by: Juan Carlos Martínez-Aguayo, et al.
Published: (2017-06-01)

Selegiline in Comparison with Methylphenidate in Treatment of Adults with Attention Deficit yperactivity Disorder: A Double-blind, Randomized Trial
by: Farbod Fadai, et al.
Published: (2009-12-01)

Selegiline in Comparison with Methylphenidate in Treatment of Adults with Attention Deficit yperactivity Disorder: A Double-blind, Randomized Trial
by: Farbod Fadai, et al.
Published: (2009-12-01)

The safe and effective use of methylphenidate in the psychiatric treatment of an adolescent with Epidermolysis Bullosa
by: Ozalp Ekinci, et al.
Published: (2013-06-01)

Methylphenidate Multiphasic Release Tablet: Bioequivalence Assessment between Two Formulations Administered under Fasting and Fed Conditions
by: Marcelo Gomes Davanço, et al.
Published: (2023-06-01)

Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: A double blind and randomized trial [ISRCTN64132371]
by: Mohammadi Mohammad-Reza, et al.
Published: (2004-04-01)

Rise, and pronounced regional variation, in methylphenidate, amphetamine, and lisdexamfetamine distribution in the United States
by: Sneha M. Vaddadi, et al.
Published: (2021-12-01)

The effect of methylphenidate on pain perception thresholds in children with attention deficit hyperactivity disorder
by: Abdullah Bozkurt, et al.
Published: (2023-10-01)

Successful treatment of attention-deficit/hyperactivity disorder accompanying to alkaptonuria with methylphenidate and risperidone
by: Asiye Arıcı, et al.
Published: (2019-01-01)

Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity
by: Huss M, et al.
Published: (2017-07-01)

Pulmonary emphysema induced by methylphenidate: experimental study
by: Gabriel Victor Guimarães Rapello, et al.

Methylphenidate use and school performance among primary school children: a descriptive study
by: Jurjen van der Schans, et al.
Published: (2017-03-01)

Atomoxetine and Methylphenidate Treatment in ADHD
by: Snircova E., et al.
Published: (2015-05-01)

Adverse reactions of Methylphenidate in children with attention deficit-hyperactivity disorder: Report from a referral center
by: Zahra Khajehpiri, et al.
Published: (2014-01-01)

The Knowledge and Attitude of the Parents of Children with ADHD toward Methylphenidate (Ritalin)
by: Sanaz Noroozi, et al.
Published: (2023-04-01)

Possible Association between Methylphenidate and Mandibular Bone Characteristics Detected by Dental Panoramic Radiograph in Children and Adolescents with ADHD
by: Hadas Kostiner, et al.
Published: (2022-08-01)

The Effect of Methylphenidate Treatment on Heart Rate Variability and Cardiac Autonomic Functions in Children with Attention Deficit Hyperactivity Disorder
by: Özgür KIZILCA, et al.
Published: (2023-03-01)

Personalized at-home neurofeedback compared with long-acting methylphenidate in an european non-inferiority randomized trial in children with ADHD
by: Stéphanie Bioulac, et al.
Published: (2019-08-01)